Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    22149875 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer (CLEOPATRA)
Condition: Metastatic Breast Cancer
Interventions: Drug: Pertuzumab;   Drug: Placebo;   Drug: Trastuzumab;   Drug: Docetaxel
2 Not yet recruiting Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Conditions: HER-2 Positive Breast Cancer;   Estrogen Receptor Positive Breast Cancer
Interventions: Drug: palbociclib;   Drug: trastuzumab;   Drug: pertuzumab;   Drug: letrozole;   Drug: Anastrozole;   Drug: Exemestane;   Drug: Fulvestrant
3 Active, not recruiting Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
Condition: Metastatic Breast Cancer
Intervention:

Study has passed its completion date and status has not been verified in more than two years.